Cervical cancer trials in Chile

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Where

  La Serena, Santiago, Temuco, Viña del Mar

  Age

  18 years and over

  People

  1,023 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07216703 · EU 2025-521514-26-00
• Phase 1/2Taking people
  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Where

  Concepción, La Serena, Santiago, Temuco

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06330064 · EU 2023-509632-26-00
• No phaseNot yet taking people in Chile
  PRIORITY Study in Cervical Cancer

  Where

  Coquimbo, Coyhaique, Santiago, Talca

  Age

  30 years to 65 years

  People

  700

  Run by

  Pontificia Universidad Catolica de Chile

  See details and how to joinNCT07593066